Fungal infections in immunocompromised individuals.
This article examines the expression of fungal infections seen with different immunodeficiency states and discusses how the sequential appearance of different diseases serves as a harbinger of clinical disease progression. The effect of an immunocompromised state on the medical history, physical findings, and natural history of fungal infections are discussed. The appearance and increased frequency of rare fungal infections, made possible by immunosuppression, are highlighted.
Conant
M A
MA
Department of Dermatology, University of California Medical Center, San Francisco, USA.
D000935:Antifungal Agents / Q000627:therapeutic use; D003881:Dermatomycoses / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D009181:Mycoses / Q000276:immunology* / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D012008:Recurrence
D000935:Antifungal Agents